Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rogaine exclusivity preliminary injunction hearing set for April 25.

This article was originally published in The Tan Sheet

Executive Summary

OTC MINOXIDIL ANDA APPROVALS SUSPENDED BY FDA under a temporary restraining order issued by Michigan federal court Judge Robert Holmes Bell on April 15. The order effectively bars generic manufacturers Alpharma, Teva and Bausch & Lomb -- all of which have received ANDA approvals for minoxidil 2% hair regrowth treatment for men -- from marketing private label versions of Pharmacia & Upjohn's OTC Rogaine until a further ruling.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085026

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel